No quarterly revenue total was found in CYPHERPUNK TECHNOLOGIES INC.'s SEC filings.
Cypherpunk Technologies Inc. (CYPH) files with the SEC under industry code 2834, Pharmaceutical Preparations. As of Jun 30, 2026 it held $7.6 million in cash and investments and $38,000 in total debt.
Revenue
—
Net income
$39.39M
+336.7% vs year-ago quarter
Operating cash flow
$-2.69M
+81.4% vs year-ago quarter
Free cash flow
—
EPS
$0.18
+145.0% vs year-ago quarter
Dividend per share
None
Shares outstanding
107.76M
+160.1% vs year-ago quarter
Net cash
$7.59M
Q2 FY2026
Operating margin
—
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CYPH (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cambridge, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1509745
- Former names
- LEAP THERAPEUTICS, INC. (until Nov 12, 2025); Dekkun Corp (until Jan 7, 2011)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Operating income | -$4.7M | -$4.8M | -$5.1M | -$3.2M | -$16.9M |
| Net income | $39.4M | -$77.2M | $40.2M | -$3.3M | -$16.6M |
| Diluted EPS | $0.18 | -$0.46 | $0.26 | -$0.08 | -$0.40 |
| Operating cash flow | -$2.7M | -$3.4M | -$6.6M | -$8.3M | -$14.5M |
| Total assets | $143.0M | $87.4M | $163.2M | $11.4M | $20.0M |
| Total liabilities | $3.6M | $3.0M | $9.7M | $8.7M | — |
| Stockholders' equity | $139.3M | $84.4M | $153.5M | $2.7M | $5.7M |
| Cash and investments | $7.6M | $6.7M | $14.0M | $9.7M | $18.1M |
| Total debt | $38,000 | $38,000 | $38,000 | $38,000 | $39,000 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 22, 2026 | Sep 22, 2026 |
| 8-K |
Current report
Other events
|
Sep 2, 2026 | Sep 2, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Aug 18, 2026 | Aug 17, 2026 |
| 10-Q | Quarterly report | Aug 12, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 12, 2026 | Aug 12, 2026 |
| 8-K |
Current report
Listing notice
|
Jul 21, 2026 | Jul 20, 2026 |
All 623 Cypherpunk Technologies Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.